1137 related articles for article (PubMed ID: 19861459)
21. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia.
Lee GY; Chun YS; Shin HW; Park JW
Oncotarget; 2016 Aug; 7(35):57442-57451. PubMed ID: 27447861
[TBL] [Abstract][Full Text] [Related]
22. Glucose metabolism and cancer.
Shaw RJ
Curr Opin Cell Biol; 2006 Dec; 18(6):598-608. PubMed ID: 17046224
[TBL] [Abstract][Full Text] [Related]
23. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
Huang LE
Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
[TBL] [Abstract][Full Text] [Related]
24. Impact of MYC in regulation of tumor cell metabolism.
Wahlström T; Henriksson MA
Biochim Biophys Acta; 2015 May; 1849(5):563-9. PubMed ID: 25038584
[TBL] [Abstract][Full Text] [Related]
25. Targeting Glutamine Induces Apoptosis: A Cancer Therapy Approach.
Chen L; Cui H
Int J Mol Sci; 2015 Sep; 16(9):22830-55. PubMed ID: 26402672
[TBL] [Abstract][Full Text] [Related]
26. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
27. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition.
Fan Y; Dickman KG; Zong WX
J Biol Chem; 2010 Mar; 285(10):7324-33. PubMed ID: 20018866
[TBL] [Abstract][Full Text] [Related]
28. Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability.
Broecker-Preuss M; Becher-Boveleth N; Bockisch A; Dührsen U; Müller S
J Transl Med; 2017 Jul; 15(1):158. PubMed ID: 28724379
[TBL] [Abstract][Full Text] [Related]
29. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC.
Liu W; Le A; Hancock C; Lane AN; Dang CV; Fan TW; Phang JM
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):8983-8. PubMed ID: 22615405
[TBL] [Abstract][Full Text] [Related]
30. c-Myc-driven glycolysis via TXNIP suppression is dependent on glutaminase-MondoA axis in prostate cancer.
Qu X; Sun J; Zhang Y; Li J; Hu J; Li K; Gao L; Shen L
Biochem Biophys Res Commun; 2018 Oct; 504(2):415-421. PubMed ID: 30103944
[TBL] [Abstract][Full Text] [Related]
31. c-Myc and cancer metabolism.
Miller DM; Thomas SD; Islam A; Muench D; Sedoris K
Clin Cancer Res; 2012 Oct; 18(20):5546-53. PubMed ID: 23071356
[TBL] [Abstract][Full Text] [Related]
32. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
[TBL] [Abstract][Full Text] [Related]
33. Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism.
Kappler M; Pabst U; Weinholdt C; Taubert H; Rot S; Kaune T; Kotrba J; Porsch M; Güttler A; Bache M; Krohn K; Bull F; Riemann A; Wickenhauser C; Seliger B; Schubert J; Al-Nawas B; Thews O; Grosse I; Vordermark D; Eckert AW
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554283
[TBL] [Abstract][Full Text] [Related]
34. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development.
Wilde L; Roche M; Domingo-Vidal M; Tanson K; Philp N; Curry J; Martinez-Outschoorn U
Semin Oncol; 2017 Jun; 44(3):198-203. PubMed ID: 29248131
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling.
Yang C; Sudderth J; Dang T; Bachoo RM; McDonald JG; DeBerardinis RJ
Cancer Res; 2009 Oct; 69(20):7986-93. PubMed ID: 19826036
[TBL] [Abstract][Full Text] [Related]
36. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia-inducible factor 1 and cancer pathogenesis.
Semenza GL
IUBMB Life; 2008 Sep; 60(9):591-7. PubMed ID: 18506846
[TBL] [Abstract][Full Text] [Related]
38. Glutaminolysis: supplying carbon or nitrogen or both for cancer cells?
Dang CV
Cell Cycle; 2010 Oct; 9(19):3884-6. PubMed ID: 20948290
[TBL] [Abstract][Full Text] [Related]
39. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth.
Gaglio D; Metallo CM; Gameiro PA; Hiller K; Danna LS; Balestrieri C; Alberghina L; Stephanopoulos G; Chiaradonna F
Mol Syst Biol; 2011 Aug; 7():523. PubMed ID: 21847114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]